Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state - PubMed (original) (raw)
. 1998 Apr 7;37(14):5010-9.
doi: 10.1021/bi973045u.
Affiliations
- PMID: 9538020
- DOI: 10.1021/bi973045u
Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state
M Ramachandra et al. Biochemistry. 1998.
Abstract
Human P-glycoprotein (Pgp), a plasma membrane protein that confers multidrug resistance, functions as an ATP-dependent drug efflux pump. Pgp contains two ATP binding/utilization sites and exhibits ATPase activity that is stimulated in the presence of substrates and modulating agents. The mechanism of coupling of ATP hydrolysis to drug transport is not known. To understand the role of ATP hydrolysis in drug binding, it is necessary to develop methods for purifying and reconstituting Pgp that retains properties including stimulation of ATPase activity by known substrates to an extent similar to that in the native membrane. In this study, (His)6-tagged Pgp was expressed in Trichoplusia ni (High Five) cells using the recombinant baculovirus system and purified by metal affinity chromatography. Upon reconstitution into phospholipid vesicles, purified Pgp exhibited specific binding to analogues of substrates and ATP in affinity labeling experiments and displayed a high level of drug-stimulated ATPase activity (specific activity ranging from 4.5 to 6.5 micromol min-1 mg-1). The ATPase activity was inhibited by ADP in a competitive manner, and by vanadate and N-ethylmaleimide at low concentrations. Vanadate which is known to inhibit ATPase activity by trapping MgADP at the catalytic site inhibited photoaffinity labeling of Pgp with substrate analogues, [125I]iodoarylazidoprazosin and [3H]azidopine, only under ATP hydrolysis conditions. Because vanadate-trapped Pgp is known to resemble the ADP and phosphate-bound catalytic transition state, our findings indicate that ATP hydrolysis results in a conformation with reduced affinity for substrates. A catalytic transition conformation with reduced affinity would essentially result in substrate dissociation and supports a model for drug transport in which an ATP hydrolysis-induced conformational change leads to drug release toward the extracellular medium.
Similar articles
- Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N, Moitra K, Silver C, Ghosh P, Chattopadhyay A, Dey S. Maki N, et al. Biochemistry. 2006 Feb 28;45(8):2739-51. doi: 10.1021/bi0521745. Biochemistry. 2006. PMID: 16489767 - Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
Tombline G, Donnelly DJ, Holt JJ, You Y, Ye M, Gannon MK, Nygren CL, Detty MR. Tombline G, et al. Biochemistry. 2006 Jul 4;45(26):8034-47. doi: 10.1021/bi0603470. Biochemistry. 2006. PMID: 16800628 - P glycoprotein and the mechanism of multidrug resistance.
Váradi A, Szakács G, Bakos E, Sarkadi B. Váradi A, et al. Novartis Found Symp. 2002;243:54-65; discussion 65-8, 180-5. Novartis Found Symp. 2002. PMID: 11990782 Review. - The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).
Ambudkar SV, Kim IW, Sauna ZE. Ambudkar SV, et al. Eur J Pharm Sci. 2006 Apr;27(5):392-400. doi: 10.1016/j.ejps.2005.10.010. Epub 2005 Dec 13. Eur J Pharm Sci. 2006. PMID: 16352426 Review.
Cited by
- Characterization of the Lipidome and Biophysical Properties of Membranes from High Five Insect Cells Expressing Mouse P-Glycoprotein.
Moreno MJ, Teles Martins PA, Bernardino EF, Abel B, Ambudkar SV. Moreno MJ, et al. Biomolecules. 2021 Mar 14;11(3):426. doi: 10.3390/biom11030426. Biomolecules. 2021. PMID: 33799403 Free PMC article. - Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes.
Wu CP, Klokouzas A, Hladky SB, Ambudkar SV, Barrand MA. Wu CP, et al. Biochem Pharmacol. 2005 Aug 15;70(4):500-10. doi: 10.1016/j.bcp.2005.05.022. Biochem Pharmacol. 2005. PMID: 16004972 Free PMC article. - Influence of passive permeability on apparent P-glycoprotein kinetics.
Lentz KA, Polli JW, Wring SA, Humphreys JE, Polli JE. Lentz KA, et al. Pharm Res. 2000 Dec;17(12):1456-60. doi: 10.1023/a:1007692622216. Pharm Res. 2000. PMID: 11303953 - Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.
Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G. Aller SG, et al. Science. 2009 Mar 27;323(5922):1718-22. doi: 10.1126/science.1168750. Science. 2009. PMID: 19325113 Free PMC article. - Mutational analysis reveals the importance of residues of the access tunnel inhibitor site to human P-glycoprotein (ABCB1)-mediated transport.
Salazar PB, Murakami M, Ranganathan N, Durell SR, Ambudkar SV. Salazar PB, et al. Protein Sci. 2024 Sep;33(9):e5155. doi: 10.1002/pro.5155. Protein Sci. 2024. PMID: 39194126
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous